National Brain Tumor Society & Oligo Nation Announce Funding for Immunotherapy-Based Approach to Oligodendroglioma Treatment
Joint funding effort will provide $250,000 for development of anti-CD47 immunotherapy at Stanford University School of Medicine National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, together with Oligo Nation, a community-driven non-profit dedicated to funding translational oligodendroglioma research, today announced $250,000 in grant-funding for a […]
May 16, 2016